MA26758A1 - NEW, MODIFIED RELEASE COMPOSITION FOR THE TREATMENT OF DIABETES. - Google Patents

NEW, MODIFIED RELEASE COMPOSITION FOR THE TREATMENT OF DIABETES.

Info

Publication number
MA26758A1
MA26758A1 MA26192A MA26192A MA26758A1 MA 26758 A1 MA26758 A1 MA 26758A1 MA 26192 A MA26192 A MA 26192A MA 26192 A MA26192 A MA 26192A MA 26758 A1 MA26758 A1 MA 26758A1
Authority
MA
Morocco
Prior art keywords
diabetes
treatment
new
release composition
modified release
Prior art date
Application number
MA26192A
Other languages
French (fr)
Inventor
Karen Lewis
Nicola Jayne Lilliott
Donald Colin Mackenzie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA26758A1 publication Critical patent/MA26758A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"Composition nouvelle, à libération modifiée, pour le traitement du diabète" L'invention concerne une composition pharmaceutique à libération modifiée. Cette composition comprend un sensibilisant à l'insuline, un autre agent antidiabétique et un support pharmaceutiquement acceptable. Application : utilisation de cette composition pour le traitement du diabète."Novel, modified-release composition for the treatment of diabetes" The invention relates to a modified-release pharmaceutical composition. This composition includes an insulin sensitizer, another anti-diabetic agent and a pharmaceutically acceptable carrier. Application: use of this composition for the treatment of diabetes.

MA26192A 1998-11-12 2001-05-11 NEW, MODIFIED RELEASE COMPOSITION FOR THE TREATMENT OF DIABETES. MA26758A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9824866.9A GB9824866D0 (en) 1998-11-12 1998-11-12 Novel composition and use

Publications (1)

Publication Number Publication Date
MA26758A1 true MA26758A1 (en) 2004-12-20

Family

ID=10842370

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26192A MA26758A1 (en) 1998-11-12 2001-05-11 NEW, MODIFIED RELEASE COMPOSITION FOR THE TREATMENT OF DIABETES.

Country Status (5)

Country Link
CN (1) CN1762494A (en)
CO (1) CO5150180A1 (en)
GB (1) GB9824866D0 (en)
MA (1) MA26758A1 (en)
ZA (1) ZA200103843B (en)

Also Published As

Publication number Publication date
CO5150180A1 (en) 2002-04-29
ZA200103843B (en) 2002-05-14
GB9824866D0 (en) 1999-01-06
CN1762494A (en) 2006-04-26

Similar Documents

Publication Publication Date Title
TNSN98211A1 (en) COMBINATION OF AN ALDOSE-REDUCTASE INHIBITOR AND A GLYCOGENE-PHOSPHORYLASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
TNSN98017A1 (en) SULFONYLUREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TR200001218T2 (en) Substituted carboxamidothiazoles, their manufacture and pharmaceutical compositions containing them.
BR0007500A (en) Triazole compound, drug, and, use of the compound
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
TNSN99053A1 (en) ACID HYDROXAMIDES (4-ARYLSULFONYLAMINO) -TETRAHYDRO- PYRANNE-4-CARBOXYLIQUES), PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
MA26728A1 (en) PHARMACEUTICAL COMPOSITION COMPRISING A CYP2D6 INHIBITOR AND A CYP2D6 CATALYZED METABOLISM DRUG
DZ2520A1 (en) Pharmaceutical composition for a method of treating diabetes mellitus.
PT958296E (en) HETEROCYCLIC COMPOUNDS PROCESS FOR THEIR PREPARATION PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND ITS UTILIZATION IN THE TREATMENT OF RELATED DIABETES AND DISEASES
MX9708621A (en) 'beta'-ADRENERGIC AGONISTS.
TNSN99006A1 (en) 4- (2-CETO-1-BENZIMIDAZOLINYL) NOVEL PIPERIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN96072A1 (en) N- (INDOLE -2-CARBONYL) -GLYCINAMIDES SUBSTITUTED, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
BR0114410A (en) Combination of a cb1 receptor antagonist and sibutramine, the pharmaceutical compositions containing them and their use for the treatment of obesity
NO993646D0 (en) Thiazole benzenesulfonamides as <beta> 3 agonists for the treatment of diabetes and obesity
ATE228360T1 (en) STABILIZED THYROID HORMONE DRUGS
PT741716E (en) ANALOGOS OF DELTA 12,13-ISO-TAXOL ITS ANTI-NEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
TNSN99203A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MIGRAINE, AND METHOD FOR THEIR PREPARATION
BR9609653A (en) Pharmaceutical compounds and compositions containing the same
TNSN99001A1 (en) 2,3-SUBSTITUTED INDOLES AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS
DZ2539A1 (en) Pharmaceutical compositions for the treatment of insulin resistance.
BR9909138A (en) Combination for the treatment of alcohol and drug addiction containing an opioid antagonist and a nmda receptor complex modulator
ES2124905T3 (en) ANTIGLUCOCORTICOID STEROIDS INTENDED FOR THE TREATMENT OF ANXIETY DISORDERS.
GB2380939B (en) Treatment or prevention of auto-immune diseases
TR199800521T1 (en) Seimli beta3 adrenerjik agonistler.
RS49734B (en) Use of intravenous cotrast agents for projection mammography